Valo Health Inc., a pioneer in the use of human data and AI to accelerate drug discovery and development, has appointed Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‑world human data into causal insights that inform drug discovery. “The creation of this position and strategic appointment underscore the importance we p...